The short answer
Product form showed a clearer relationship. Tablets tended to perform better than powders in relative popularity, while chews occupied the broad middle of the market.
Brand showed an even stronger association with popularity.
And products associated with stronger scientific evidence were not automatically more popular.
Market popularity and scientific support measure different things.
For buyers, price is better treated as a budget and value factor rather than a shortcut for trust or effectiveness.
1. Product form appears to matter
Across the main product forms, popularity was not evenly distributed. Tablets tended to rank better than powders, while chews formed the largest and most common group.
This does not mean tablets work better biologically. Administration format may instead influence convenience, routine fit, owner adherence and market adoption.
2. Brand showed a stronger relationship with popularity
Brand was one of the stronger factors associated with relative popularity in this cohort.
This does not prove that brand recognition causes purchases. Established brands may also benefit from longer time on the market, distribution, search visibility, repeat customers, accumulated reviews, advertising and retailer placement.
A highly visible product can therefore be popular partly because the brand already has strong market presence, not necessarily because its ingredients are scientifically superior.
3. Popularity and scientific evidence are not the same thing
Some ingredient categories used in dog joint supplements have stronger canine clinical evidence than others (see the ingredient-by-ingredient summary below).
However, stronger ingredient-level evidence did not automatically correspond to the most popular products in the marketplace. Glucosamine appears in most of the products we compared, yet a placebo-controlled trial with activity monitors and a 2022 meta-analysis found little or no pain benefit for glucosamine–chondroitin products.[3][4] The full breakdown is in Best-selling dog joint supplements vs the evidence.
Popularity describes market adoption. Scientific evidence describes what controlled research has found about particular ingredients, formulations, populations and outcomes.
Neither should be substituted for the other.
4. What the canine evidence shows, ingredient by ingredient
Our ratings follow the rules in our methodology: VERIFIED_SUPPORTIVE needs at least two randomized controlled trials of the ingredient itself with a between-group benefit on the main clinical outcomes, or one such trial plus a supportive systematic review. Ratings were last re-checked on September 29, 2026.
| Ingredient | Our rating | Key canine evidence |
|---|---|---|
| Omega-3 (EPA/DHA from fish oil) | Supportive | Several randomized trials improved weight bearing, lameness or mobility, including a 38-dog force-plate trial of a fish-oil-enriched food and a 78-dog placebo-controlled trial at about 69 mg EPA+DHA/kg/day. A 77-dog fish-oil trial was null on its main outcomes. A 2022 meta-analysis ranked omega-3 among the better-supported options.[1][2][5][4] |
| Green-lipped mussel | Supportive | An 81-dog placebo-controlled extract trial (more dogs improved by day 56) and a 45-dog trial in which green-lipped mussel beat placebo but was less effective than carprofen.[6][7] |
| UC-II (undenatured type II collagen, about 40 mg a day) | Supportive | Small placebo-controlled trials, mostly from one research group, plus a 60-dog trial with changes similar to the anti-inflammatory drug robenacoxib. Applies only to the UC-II preparation, not to other collagen.[8][9] |
| Glucosamine + chondroitin | Mixed | An early positive trial had no placebo group; a 60-dog placebo-controlled trial with activity monitors found no difference, and a 2022 meta-analysis found a pronounced lack of pain benefit.[10][3][4] |
| Turmeric / Boswellia | Mixed | The main turmeric-extract trial missed its force-plate primary outcome, while investigator scores favored treatment; Boswellia data are uncontrolled.[11][12] |
| Eggshell membrane | Mixed | A manufacturer-run 51-dog trial found less pain than placebo at some time points but not others; a 22-dog pilot was positive on one owner scale only.[13][14] |
| MSM, hyaluronic acid | Insufficient | No dog trial of MSM alone; the one canine trial of oral hyaluronic acid alone measured joint-fluid markers, not pain or lameness (full review). |
| ASU (avocado/soybean) | Insufficient | Tested alone only in a surgical arthritis model in 16 dogs; clinical trials used multi-ingredient products (full review). |
| Collagen other than UC-II | Not assessed | Does not inherit the UC-II evidence. |
Full reviews: omega-3, green-lipped mussel, UC-II, glucosamine, chondroitin, turmeric and Boswellia, eggshell membrane, MSM and hyaluronic acid, ASU.
5. What should a dog owner actually look at?
A practical comparison should not rely on one signal.
- Form affects how realistically the product can be administered.
- Price affects whether long-term use is practical.
- Popularity provides context about relative market adoption.
- Ingredients tell you what the formula is built around.
- Scientific evidence helps distinguish research support from marketing language.
A more useful question is: Which combination of form, price, ingredients, evidence and practical fit makes sense for this dog?
How to check a label before you buy
Start with the formula, not the marketing claim. A useful label tells you what the active ingredients are, how much the dog gets per day, and which form is used, so you can check whether dog studies apply to that same intervention.
- Define the goal. General mobility in a healthy dog, stiffness in an older dog and diagnosed osteoarthritis are different questions. Evidence from dogs with osteoarthritis does not automatically prove a wellness benefit.
- Identify the exact ingredient. Glucosamine alone is not glucosamine + chondroitin. Generic collagen is not UC-II. “Fish oil” means more when EPA and DHA are listed in mg.
- Check the daily amount, but don’t rank by milligrams. UC-II is studied at about 40 mg a day and glucosamine at hundreds of mg; milligrams measure mass, not potency. Use the dose checker to compare a label with study doses.
- Keep evidence levels separate. Ingredient evidence, formula evidence and exact-product evidence are different. A positive combination trial cannot identify the active component, and a single-ingredient study cannot validate a six-ingredient chew.
- Look at the outcome measured. Owner pain scores, veterinarian ratings, activity monitors and force plates answer related but different questions. A cartilage biomarker is not proof of less pain.
- Proprietary blends hide amounts. Without individual amounts, a product often cannot be matched to any study.
- Quality is not efficacy. Batch testing and good manufacturing help with quality; they do not show that a product relieves joint pain.
Checklist
- What is the intended use: wellness, stiffness, or diagnosed osteoarthritis?
- What exactly are the active ingredients, and in which form?
- How much does the dog get per day, and is each active quantified?
- Is the evidence from dogs, with the same form or formula?
- Was a relevant clinical outcome measured?
- Is the evidence for the ingredient, the formula, or the exact product?
- Is there enough label information to connect the product to the evidence?
If the chain from label to study cannot be matched, the honest conclusion is evidence match uncertain. For persistent lameness or pain, a veterinary examination comes first; supplements are adjuncts, not a replacement for pain management.
How to use the comparison table
Start by narrowing products according to your practical constraints, then compare:
Ingredients and form → Product focus → Relative popularity → Scientific evidence → Amazon listing
This keeps different information types separate instead of turning them into a single unsupported “best product” score.
What this analysis does — and does not — tell us
This analysis is observational. It does not establish that brand, price or product form causes higher or lower sales.
Customer popularity is relative to products within this comparison. Marketplace signals can be influenced by product age, promotion, distribution, brand visibility, listing quality and other factors.
Scientific evidence is evaluated separately from marketplace popularity. Evidence supporting an ingredient or related formulation does not prove that every commercial product containing that ingredient will produce the same result.
For pain, lameness, arthritis, medication decisions or other medical concerns, veterinary clinical advice remains important.
The takeaway
Popularity is useful information, but it should not make the decision for you.
In this cohort, product form showed a relationship with popularity, brand showed a stronger association, and scientific evidence did not automatically translate into market popularity.
Dog Supplement Facts therefore presents these signals separately rather than labeling one supplement as universally “best.”
Compare 205 Dog Joint Supplements
References
- Roush JK, et al. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. J Am Vet Med Assoc. 2010;236(1):67–73. PMID: 20043801. doi:10.2460/javma.236.1.67
- Mehler SJ, et al. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. Prostaglandins Leukot Essent Fatty Acids. 2016;109:1–7. PMID: 27269707. doi:10.1016/j.plefa.2016.03.015
- Scott RM, Evans R, Conzemius MG. Efficacy of an oral nutraceutical for the treatment of canine osteoarthritis: a double-blind, randomized, placebo-controlled prospective clinical trial. Vet Comp Orthop Traumatol. 2017;30(5):318–323. doi:10.3415/VCOT-17-02-0020
- Barbeau-Grégoire M, et al. A 2022 systematic review and meta-analysis of enriched therapeutic diets and nutraceuticals in canine and feline osteoarthritis. Int J Mol Sci. 2022;23(18):10384. PMID: 36142319. doi:10.3390/ijms231810384
- Hielm-Björkman A, et al. An un-commissioned randomized, placebo-controlled double-blind study to test the effect of deep sea fish oil as a pain reliever for dogs suffering from canine OA. BMC Vet Res. 2012;8:157. PMID: 22950577. doi:10.1186/1746-6148-8-157
- Pollard B, et al. Clinical efficacy and tolerance of an extract of green-lipped mussel in dogs presumptively diagnosed with degenerative joint disease. N Z Vet J. 2006;54(3):114–118. PMID: 16751841. doi:10.1080/00480169.2006.36622
- Hielm-Björkman A, et al. Evaluating complementary therapies for canine osteoarthritis part I: green-lipped mussel. Evid Based Complement Alternat Med. 2009;6(3):365–373. PMID: 18955269. doi:10.1093/ecam/nem136
- Gupta RC, et al. Comparative therapeutic efficacy and safety of type-II collagen (UC-II), glucosamine and chondroitin in arthritic dogs: pain evaluation by ground force plate. J Anim Physiol Anim Nutr. 2012;96(5):770–777. doi:10.1111/j.1439-0396.2011.01166.x
- Stabile M, et al. Evaluation of the effects of undenatured type II collagen (UC-II) as compared to robenacoxib on the mobility impairment induced by osteoarthritis in dogs. Vet Sci. 2019;6(3):72. PMID: 31487772. doi:10.3390/vetsci6030072
- McCarthy G, et al. Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. Vet J. 2007;174(1):54–61. PMID: 16647870. doi:10.1016/j.tvjl.2006.02.015
- Innes JF, et al. Randomised, double-blind, placebo-controlled parallel group study of P54FP for the treatment of dogs with osteoarthritis. Vet Rec. 2003;152(15):457–460. PMID: 12723628. doi:10.1136/vr.152.15.457
- Reichling J, et al. Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. Schweiz Arch Tierheilkd. 2004;146(2):71–79. PMID: 14994484. doi:10.1024/0036-7281.146.2.71
- Ruff KJ, Kopp KJ, et al. Effectiveness of NEM® brand eggshell membrane in the treatment of suboptimal joint function in dogs: a multicenter, randomized, double-blind, placebo-controlled study. Vet Med (Auckl). 2016. PMID: 30050844. https://pubmed.ncbi.nlm.nih.gov/30050844/
- Müller C, et al. Placebo-controlled pilot study of the effects of an eggshell membrane-based supplement on mobility and serum biomarkers in dogs with osteoarthritis. Vet J. 2019;253:105379. PMID: 31685140. https://pubmed.ncbi.nlm.nih.gov/31685140/